In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes

References

• Battaglia G, La Russa M, Bruno V, Arenare L, Ippolito R, Copani A, Bonina F, Nicoletti F. (2000). Systemically administered D-glucose conjugates of 7-chlorokynurenic acid are centrally available and exert anticonvulsant activity in rodents. Brain Res, 860, 149–156.
   PubMed Web of Science ®Google Scholar
• Begley DJ, Brightman MW. (2003). Structural and functional aspects of the blood-brain barrier. Prog Drug Res, 61, 39–78.
   PubMedGoogle Scholar
• Begley DJ. (2004). Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther, 104, 29–45.
   PubMed Web of Science ®Google Scholar
• Bonina FP, Arenare L, Ippolito R, Boatto G, Battaglia G, Bruno V, de Caprariis P. (2000). Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs. Int J Pharm, 202, 79–88.
   PubMed Web of Science ®Google Scholar
• Chen Q, Gong T, Liu J, Wang X, Fu H, Zhang Z. (2009). Synthesis in vitro and in vivo Characterization of Glycosyl Derivatives of Ibuprofen as Novel Prodrugs for Brain Drug Delivery. J Drug Target, 4, 318–328.
   Google Scholar
• Chertok B, David AE, Moffat BA, Yang VC. (2009). Substantiating in vivo magnetic brain tumor targeting of cationic iron oxidenanocarriers via adsorptive surface masking. Biomaterials, 30, 6780–6787.
   PubMed Web of Science ®Google Scholar
• Choeiri C, Staines W, Messier C. (2002). Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience, 111, 19–34.
   PubMed Web of Science ®Google Scholar
• Dick AP, Harik SI, Klip A, Walker DM. (1984). Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc Natl Acad Sci USA, 81, 7233–7237.
   PubMed Web of Science ®Google Scholar
• Du J, Lu WL, Ying X, Liu Y, Du P, Tian W, Men Y, Guo J, Zhang Y, Li RJ, Zhou J, Lou JN, Wang JC, Zhang X, Zhang Q. (2008). Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals. Mol Pharm, 6, 905–917
   Google Scholar
• Dufes C, Gaillard F, Uchegbu IF, Schätzlein AG, Olivier JC, Muller JM. (2004). Glucose-targeted niosomes deliver vasoactive intestinal peptide (VIP) to the brain. Int J Pharm, 285, 77–85.
   PubMed Web of Science ®Google Scholar
• Dwyer DS, Vannucci SJ, Simpson IA. (2002). Expression, regulation, and functional role of glucose transporters (GLUTs) in brain. Int Rev Neurobiol, 51, 159–188.
   PubMed Web of Science ®Google Scholar
• Fernández C, Nieto O, Rivas E, Montenegro G, Fontenla JA, Fernández-Mayoralas A. (2000). Synthesis and biological studies of glycosyl dopamine derivatives as potential antiparkinsonian agents. Carbohydr Res, 327, 353–365.
   PubMed Web of Science ®Google Scholar
• Francesco B, Carmelo P, Maria GR, Daniela M, Giampiero B, Maria N, Antonio C, Giovanna LR Paolo De C. (2003). Glycosyl Derivatives of Dopamine and L-dopa as Anti-Parkinson Prodrugs: Synthesis, Pharmacological Activity and In Vitro Stability Studies. J Drug Target, 11, 25–36.
   PubMed Web of Science ®Google Scholar
• Halmos T, Santarromana M, Antonakis K, Scherman D. (1997). Synthesis of O-methylsulfonyl derivatives of D-glucose as potential alkylating agents for targeted drug delivery to the brain. Evaluation of their interaction with the human erythrocyte GLUT1 hexose transporter. Carbohydr Res, 299, 15–21.
   PubMed Web of Science ®Google Scholar
• Han HD, Lee A, Song CK, Hwang T, Seong H, Lee CO, Shin BC. (2006). In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. Int J Phar, 313, 181–188.
   PubMed Web of Science ®Google Scholar
• Hu K, Li J, Shen Y, Lu W, Gao X, Zhang Q, Jiang X. (2009). Lactoferrin-conjugated PEG–PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations. J Control Release, 134, 55–61.
   PubMed Web of Science ®Google Scholar
• Huwyler J, Cerletti A, Fricker G, Eberle AN, Drewe J. (2002). By-passing of P-glycoprotein using immunoliposomes. J Drug Target, 10, 73–79.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Bhandari R, Bhandari S, Kakkar V. (2008). Potential of solid lipid nanoparticles in brain targeting. J Control Release, 127, 97–109.
   PubMed Web of Science ®Google Scholar
• Jeliazkova-Mecheva VV, Bobilya DJ. (2003). A porcine astrocyte/endothelial cell co-culture model of the blood–brain barrier. Brain Res Brain Res Protocols, 12, 91–98.
   PubMedGoogle Scholar
• LaManna JC, Harik SI. (1985). Regional comparisons of brain glucose influx. Brain Res, 326, 299–305.
   PubMed Web of Science ®Google Scholar
• Lu W, Tan YZ, Hu KL, Jiang XG. (2005). Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood–brain barrier. Int J Pharm, 295, 247–260.
   PubMed Web of Science ®Google Scholar
• McEwen BS, Reagan LP. (2004). Glucose transporter expression in the central nervous system: relationship to synaptic function. Eur J Pharmacol, 490, 13–24.
   PubMed Web of Science ®Google Scholar
• Nualart F, Godoy A, Reinicke K. (1999). Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain. Brain Res, 824, 97–104.
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2003). Blood-brain barrier drug targeting: the future of brain drug development. Mol. Interv, 3, 90–105.
   PubMedGoogle Scholar
• Pardridge WM. (2005). Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems. Int Con Series, 1277, 49–62.
   Google Scholar
• Pifferi F, Jouin M, Alessandri JM, Haedke U, Roux F, Perrière N, Denis I, Lavialle M, Guesnet P. (2007). n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. Prostaglandins Leukot Essent Fatty Acids, 77, 279–286.
   PubMed Web of Science ®Google Scholar
• Polt R, Porreca F, Szabò LZ, Bilsky EJ, Davis P, Abbruscato TJ, Davis TP, Harvath R, Yamamura HI, Hruby VJ. (1994). Glycopeptide enkephalin analogues produce analgesia in mice: Evidence for penetration of the blood–brain barrier. Proc Natl Acad Sci USA, 91, 7114–7118.
   PubMed Web of Science ®Google Scholar
• Qutub AA, Hunt CA. (2005). Glucose transport to the brain: a systems model. Brain Res Brain Res Rev, 49, 595–617.
   PubMed Web of Science ®Google Scholar
• Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, Mallikarjuana NN, Manohar S, Liang HF, Kulkarni AR, Sung HW, Sairam M, Aminabhavi TM. (2005). Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer’s disease. J Control Release, 108, 193–214.
   PubMed Web of Science ®Google Scholar
• Schubert D. (2005). Glucose metabolism and Alzheimer’s disease. Ageing Res Rev, 4, 240–257.
   PubMed Web of Science ®Google Scholar
• Shimada K, Kamps JA, Regts J, Ikeda K, Shiozawa T, Hirota S, Scherphof GL. (1997). Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s. Biochim Biophys Acta, 1326, 329–341.
   PubMed Web of Science ®Google Scholar
• Siflinger-Birnboim A, Del Vecchio PJ, Cooper JA, Blumenstock FA, Shepard JM, Malik AB. (1987). Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol, 132, 111–117.
   PubMed Web of Science ®Google Scholar
• Temsamani J, Scherrmann JM, Rees AR, Kaczorek M. (2000). Brain drug delivery technologies: novel approaches for transporting therapeutics. Pharm Sci Technol Today, 3, 155–162.
   PubMedGoogle Scholar
• Xie Y, Ye L, Zhang X, Cui W, Lou J, Nagai T, Hou X. (2005). Transport of nerve growth factor encapsulated into liposomes across the blood–brain barrier: In vitro and in vivo studies. J Control Release, 105, 106–119.
   PubMed Web of Science ®Google Scholar
• Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, Zhang Y, Li RJ, Yang TY, Shang DW, Lou JN, Zhang LR, Zhang Q. (2009). Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release, [Epub ahead of print].
   PubMed Web of Science ®Google Scholar
• Zhao XB, Muthusamy N, Byrd JC, Lee RJ. (2007). Cholesterol as a Bilayer Anchor for PEGylation and Targeting Ligand in Folate-Receptor-Targeted Liposomes. J Pharm Sci, 96, 2424–2435.
   PubMed Web of Science ®Google Scholar
• Zhi RZ, Wei ZL, Nagai, T. (2001). Studies on hydrolysis kinetics and photolysis kinetics of N1- retinoyl-5-fluorouracil. STP Pharma Sci, 11, 243–246.
   Google Scholar